Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepime
- 1 July 1997
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 28 (3) , 119-122
- https://doi.org/10.1016/s0732-8893(97)00012-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinationsAntimicrobial Agents and Chemotherapy, 1993
- Susceptibility ofMycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 1991
- Permeability barrier to hydrophilic solutes in Mycobacterium cheloneiJournal of Bacteriology, 1990
- In-vitro synergistic activity between ethambutol and fluorinated qoinolones against Mycobacterium avium complexJournal of Antimicrobial Chemotherapy, 1989
- Synergistic effects of antimycobacterial drag combinations onMycobacterium avium complex determined radiometrically in liquid mediumEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activities of ampicillin, BMY 28142, and imipenem against Mycobacterium avium complexDiagnostic Microbiology and Infectious Disease, 1987
- Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1983
- The Nature of Mycobacterial Penicillinase1American Review of Respiratory Disease, 1965